Finanzdaten der Trisalus Life Sciences Inc-Aktie (TLSI)
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 28.18%11.41 | 8.90 | 13.21 | 11.57 | 11.21 |
| Cost Of Revenue | 22.60%1.51 | 1.23 | 1.76 | 1.91 | 1.80 |
| Gross Profit | 29.08%9.90 | 7.67 | 11.44 | 9.66 | 9.41 |
2.46%3.14 | 3.22 | - | - | - | |
| Research and Development | 2.46%3.14 | 3.22 | - | - | - |
| Depreciation and Amortization | 0.74%0.14 | 0.14 | 0.13 | 0.16 | 0.17 |
| Operating Income/Loss | 16.67%-9.81 | -8.41 | -3.27 | -9.01 | -7.33 |
| Income/Loss From Continuing Operations Before Tax | 695.14%-9.18 | 1.54 | -9.75 | -10.81 | -8.29 |
| Income Tax Expense/Benefit | 0.00 | 0.00 | - | 0.01 | -0.00 |
696.95%-9.19 | 1.54 | -9.75 | -10.81 | -8.29 | |
| Attributable To Parent | 696.95%-9.19 | 1.54 | -9.75 | -10.81 | -8.29 |
| Available To Common Stockholders, Basic | 696.95%-9.19 | 1.54 | -9.75 | -41.27 | -9.00 |
| Preferred Stock Dividends And Other Adjustments | - | - | - | - | 0.71 |
| Basic Average Shares | 13.11%58.30 | 51.54 | 3.04 | 43.06 | 32.90 |
| Diluted Average Shares | 11.44%58.30 | 52.31 | 3.04 | 43.06 | 32.90 |
| Basic Earnings Per Share | 633.33%-0.16 | 0.03 | -0.12 | -0.96 | -0.27 |
| Diluted Earnings Per Share | 633.33%-0.16 | 0.03 | -0.12 | -0.96 | -0.27 |